Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

1.

Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.

Flynn RL, Cox KE, Jeitany M, Wakimoto H, Bryll AR, Ganem NJ, Bersani F, Pineda JR, Suvà ML, Benes CH, Haber DA, Boussin FD, Zou L.

Science. 2015 Jan 16;347(6219):273-7. doi: 10.1126/science.1257216.

PMID:
25593184
[PubMed - indexed for MEDLINE]
2.

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Vinagre J, Pinto V, Celestino R, Reis M, Pópulo H, Boaventura P, Melo M, Catarino T, Lima J, Lopes JM, Máximo V, Sobrinho-Simões M, Soares P.

Virchows Arch. 2014 Aug;465(2):119-33. doi: 10.1007/s00428-014-1608-4. Epub 2014 Jul 22. Review.

PMID:
25048572
[PubMed - indexed for MEDLINE]
3.

The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.

Tian XP, Qian D, He LR, Huang H, Mai SJ, Li CP, Huang XX, Cai MY, Liao YJ, Kung HF, Zeng YX, Xie D.

Cancer Lett. 2014 Oct 10;353(1):104-14. doi: 10.1016/j.canlet.2014.07.012. Epub 2014 Jul 18.

PMID:
25045845
[PubMed - indexed for MEDLINE]
4.

Association between leukocyte telomere length and vascular dementia and cancer mortality in an elderly population.

Chen C, Upton C, Braidy N, Khalil J, Fang ZM, Xu YH, Chan DK.

J Am Geriatr Soc. 2014 Jul;62(7):1384-6. doi: 10.1111/jgs.12910. No abstract available.

PMID:
25039510
[PubMed - indexed for MEDLINE]
5.

Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study.

Sun Y, Gu J, Ajani JA, Chang DW, Wu X, Stroehlein JR.

Cancer. 2014 Oct 1;120(19):3040-8. doi: 10.1002/cncr.28792. Epub 2014 Jun 24.

PMID:
24962126
[PubMed - indexed for MEDLINE]
6.

High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis.

Zhang DH, Chen JY, Hong CQ, Yi DQ, Wang F, Cui W.

Cancer. 2014 Sep 1;120(17):2673-83. doi: 10.1002/cncr.28797. Epub 2014 May 19.

PMID:
24840723
[PubMed - indexed for MEDLINE]
7.

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.

Liu T, Brown TC, Juhlin CC, Andreasson A, Wang N, Bäckdahl M, Healy JM, Prasad ML, Korah R, Carling T, Xu D, Larsson C.

Endocr Relat Cancer. 2014 May 6;21(3):427-34. doi: 10.1530/ERC-14-0016. Print 2014 Jun.

PMID:
24803525
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.

Wang N, Xu D, Sofiadis A, Höög A, Vukojević V, Bäckdahl M, Zedenius J, Larsson C.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1571-9. doi: 10.1210/jc.2014-1158. Epub 2014 Apr 23.

PMID:
24758186
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Positive association of long telomeres with the invasive capacity of hepatocellular carcinoma cells.

Ko E, Jung G.

Biochem Biophys Res Commun. 2014 May 2;447(2):358-63. doi: 10.1016/j.bbrc.2014.04.022. Epub 2014 Apr 13.

PMID:
24732358
[PubMed - indexed for MEDLINE]
10.

Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases.

Dogeas E, Karagkounis G, Heaphy CM, Hirose K, Pawlik TM, Wolfgang CL, Meeker A, Hruban RH, Cameron JL, Choti MA.

J Am Coll Surg. 2014 Apr;218(4):628-35. doi: 10.1016/j.jamcollsurg.2014.01.001. Epub 2014 Jan 10.

PMID:
24655849
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Li-Fraumeni syndrome: cancer risk assessment and clinical management.

McBride KA, Ballinger ML, Killick E, Kirk J, Tattersall MH, Eeles RA, Thomas DM, Mitchell G.

Nat Rev Clin Oncol. 2014 May;11(5):260-71. doi: 10.1038/nrclinonc.2014.41. Epub 2014 Mar 18. Review.

PMID:
24642672
[PubMed - indexed for MEDLINE]
12.

X-linked dyskeratosis congenita presenting in adulthood with photodamaged skin and epiphora.

Powell JB, Dokal I, Carr R, Taibjee S, Cave B, Moss C.

Clin Exp Dermatol. 2014 Apr;39(3):310-4. doi: 10.1111/ced.12272.

PMID:
24635067
[PubMed - indexed for MEDLINE]
13.

Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors.

Duggan C, Risques R, Alfano C, Prunkard D, Imayama I, Holte S, Baumgartner K, Baumgartner R, Bernstein L, Ballard-Barbash R, Rabinovitch P, McTiernan A.

J Natl Cancer Inst. 2014 Apr;106(4):dju035. doi: 10.1093/jnci/dju035. Epub 2014 Mar 13.

PMID:
24627273
[PubMed - indexed for MEDLINE]
14.

Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis.

Girinsky T, M'Kacher R, Lessard N, Koscielny S, Elfassy E, Raoux F, Carde P, Santos MD, Margainaud JP, Sabatier L, Ghalibafian M, Paul JF.

Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):59-66. doi: 10.1016/j.ijrobp.2014.01.021. Epub 2014 Mar 7.

PMID:
24613809
[PubMed - indexed for MEDLINE]
15.

Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging?

Pallis AG, Hatse S, Brouwers B, Pawelec G, Falandry C, Wedding U, Lago LD, Repetto L, Ring A, Wildiers H.

J Geriatr Oncol. 2014 Apr;5(2):204-18. doi: 10.1016/j.jgo.2013.09.001. Epub 2013 Sep 29. Review.

PMID:
24495695
[PubMed - indexed for MEDLINE]
16.

Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens.

Cai H, Kumar N, Bagheri HC, von Mering C, Robinson MD, Baudis M.

BMC Genomics. 2014 Jan 29;15:82. doi: 10.1186/1471-2164-15-82.

PMID:
24476156
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

Wu RC, Ayhan A, Maeda D, Kim KR, Clarke BA, Shaw P, Chui MH, Rosen B, Shih IeM, Wang TL.

J Pathol. 2014 Mar;232(4):473-81. doi: 10.1002/path.4315.

PMID:
24338723
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways.

Onodera Y, Nam JM, Bissell MJ.

J Clin Invest. 2014 Jan;124(1):367-84. doi: 10.1172/JCI63146. Epub 2013 Dec 9.

PMID:
24316969
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.

Liu JY, Qian D, He LR, Li YH, Liao YJ, Mai SJ, Tian XP, Liu YH, Zhang JX, Kung HF, Zeng YX, Zhou FJ, Xie D.

Mol Cancer. 2013 Nov 23;12(1):148. doi: 10.1186/1476-4598-12-148.

PMID:
24268029
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression.

Panero J, Stanganelli C, Arbelbide J, Fantl DB, Kohan D, García Rivello H, Rabinovich GA, Slavutsky I.

Blood Cells Mol Dis. 2014 Feb-Mar;52(2-3):134-9. doi: 10.1016/j.bcmd.2013.10.002. Epub 2013 Nov 14.

PMID:
24239198
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk